Fusion Pharmaceuticals Inc
NASDAQ:FUSN 4:00:00 PM EDT
| Market Cap (Intraday) | 1.82B |
| Current PE | N/A |
| Forward PE | N/A |
| 2yr Forward PE | N/A |
| 10-Day MA | $21.31 |
| 50-Day MA | $16.86 |
| 200-Day MA | $8.17 |
Fusion Pharmaceuticals Inc Stock, NASDAQ:FUSN
270 Longwood Road South, Hamilton, Ontario L8P 0A6
Canada
Phone: +1.289.799.0891
Number of Employees: 113
Description
Fusion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It develops GMP manufacturing of radiopharmaceuticals for the diagnosis and treatment of disease. The company was founded by John Vaillant in 2014 and is headquartered in Hamilton, Canada.